Shorts

1:16
Primary Phase 2 Results for CAR T-Cell Therapy in gMG
11 hours ago
by
Marco Meglio(+1 more)

1:17
RECAP: Neurology News Network - September 26th
4 days ago
by
Louie Pasculli

0:57
What Other Nerve Conditions Are Teaching Us About Reversing DPN
5 days ago
by
Brian Callaghan, MD, MS

0:57
The 5 to 10 Year Outlook for Diabetic Peripheral Neuropathy
6 days ago
by
Brian Callaghan, MD, MS

0:49
The Research Gaps Standing Between DPN and Reversibility
7 days ago
by
Brian Callaghan, MD, MS

1:51
Advice on Long-Term Strategies for Secondary Stroke Prevention
8 days ago
by
Eva Mistry, MD (+1 more)

1:09
What Should Neurologists Know About Cluster Headache: Part 2
10 days ago
by
Minali Nigam, MD(+1 more)

1:13
What Should Neurologists Know About Cluster Headache: Part 1
11 days ago
by
Jennifer Fokas, MD(+1 more)

1:34
RECAP: Neurology News Network - September 19th
11 days ago
by
Louie Pasculli

0:57
The Future Vision Behind the New Stroke Guidelines
15 days ago
by
Marco Meglio(+1 more)

1:06
What Is the Most Significant Shift in Treating Hypersomnia?
17 days ago
by
KuangHua Guo, MD, PhD(+1 more)

1:44
What Should Clinicians Know About “Brain Fog” From Long COVID?
18 days ago
by
Jacqueline Becker, PhD(+1 more)

1:36
RECAP: Neurology News Network - September 12th
18 days ago
by
Louie Pasculli

1:00
The Broader Lessons From Zilganersen's Path to Approval
20 days ago
by
Amy Waldman, MD

0:52
Why Patients Should Speak Up About Their Concerns Early
21 days ago
by
Mitzi Joi Williams, MD

1:35
The Missing Step Between iPSC Drug Screening and Clinical Trials
21 days ago
by
Ahmet Hoke, MD, PhD

0:35
What iPSC Models Miss About the Nervous System
22 days ago
by
Ahmet Hoke, MD, PhD

1:28
Building a Smarter Drug Development Pipeline for Neuropathy
22 days ago
by
Ahmet Hoke, MD, PhD

0:48
Why Animal Models Still Matter in Neuropathy Research
23 days ago
by
Ahmet Hoke, MD, PhD

1:28
Comorbidity Management in the New AHA/ASA Stroke Guideline
23 days ago
by
Marco Meglio(+1 more)

1:23
What’s Different About the Players Who Don’t Develop CTE?
24 days ago
by
Louie Pasculli(+1 more)

1:46
More Than 90% of Donated Brains From Former NFL Players Had CTE
25 days ago
by
Louie Pasculli(+1 more)

1:36
RECAP: Neurology News Network - September 5th
25 days ago
by
Louie Pasculli

0:48
Breaking Down Tavapadon's Phase 3 Efficacy Results
a month ago
by
Cindy Zadikoff, MD, MSc

0:57
Tavapadon's Potential Role Across the Parkinson Disease Spectrum
a month ago
by
Cindy Zadikoff, MD, MSc

1:35
Interpreting CTE Risk in Current and Former Football Players
a month ago
by
Thayne Munce, PhD(+1 more)

1:08
Preventative Vs. Acute Migraine Therapy
a month ago
by
Mitzi Joi Williams, MD

1:22
RECAP: Neurology News Network - Week of August 29th
a month ago
by
Louie Pasculli

1:00
Botox Misconceptions Everyone Believes
a month ago
by
Mitzi Joi Williams, MD

1:08
The Hidden Dangers of Overusing Pain Medication
a month ago
by
Mitzi Joi Williams, MD
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
FDA Approves Tavapadon for the Treatment of Parkinson Disease
2
FDA Accepts Fenebrutinib NDA Under Priority Review for Relapsing and Primary Progressive MS
3
ADHERE REAL Study to Assess Real-World Effectiveness of Efgartigimod in CIDP
4
Phase 4 OCTAGON Trial to Test Rapid Steroid Taper With Ravulizumab
5
